Data from CB Insights shows growth equity investing in healthcare tech is expanding at a 20% growth rate, with AI diagnostics platforms closing large Series D rounds at record-high valuations in H1 Over two decades, Vita Coco fended off competition even from the likes of beverage giants Coca-Cola (NYSE: KO) and Pepsi (NASDAQ: PEP) . In 2009, Coca-Cola purchased the Zico brand, and Pepsi purchased the O.N.E. brand. But by 2021, Coca-Cola wound up selling Zico back to its founder, and Pepsi ended up selling O.N.E., along with other juice brands, to a private equity firm. “Harnessing AI to Accelerate Innovation in the Biopharmaceutical Industry,” Information Technology & Innovation Foundation, November 15, 2024. In growth equity investing, PE-led rounds in EV manufacturing have soared, with production forecast models indicating volume growth exceeding 40% over the next two fiscal years, pushing valuations to 9x forward sales.